Rebif New Formulation (RNF) in Relapsing Forms of Multiple Sclerosis

Clinical trial NCT00110396 · COMPLETED

Trial details

NCT number: NCT00110396
Sponsor: EMD Serono
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2005-01-01
Primary completion: 2007-04-01
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.